New pyrrole derivatives with potent tubulin polymerization inhibiting activity as anticancer agents including hedgehog-dependent cancer.

We synthesized 3-aroyl-1-arylpyrrole (ARAP) derivatives as potential anticancer agents having different substituents at the pendant 1-phenyl ring. Both the 1-phenyl ring and 3-(3,4,5-trimethoxyphenyl)carbonyl moieties were mandatory to achieve potent inhibition of tubulin polymerization, binding of colchicine to tubulin, and cancer cell growth. ARAP 22 showed strong inhibition of the P-glycoprotein-overexpressing NCI-ADR-RES and Messa/Dx5MDR cell lines. Compounds 22 and 27 suppressed in vitro the Hedgehog signaling pathway, strongly reducing luciferase activity in SAG treated NIH3T3 Shh-Light II cells, and inhibited the growth of medulloblastoma D283 cells at nanomolar concentrations. ARAPs 22 and 27 represent a new potent class of tubulin polymerization and cancer cell growth inhibitors with the potential to inhibit the Hedgehog signaling pathway.

[1]  A. Thor,et al.  Reconstitution of caspase 3 sensitizes MCF-7 breast cancer cells to doxorubicin- and etoposide-induced apoptosis. , 2001, Cancer research.

[2]  N. Lawrence,et al.  Combretastatin-like chalcones as inhibitors of microtubule polymerization. Part 1: synthesis and biological evaluation of antivascular activity. , 2009, Bioorganic & medicinal chemistry.

[3]  B. Bhattacharyya,et al.  anti-Mitotic Activity of Colchicine and the Structural Basis for Its Interaction with Tubulin , 2008 .

[4]  T. Beckers,et al.  Natural, semisynthetic and synthetic microtubule inhibitors for cancer therapy , 2003 .

[5]  T. Gorojankina,et al.  Virtual Screening-Based Discovery and Mechanistic Characterization of the Acylthiourea MRT-10 Family as Smoothened Antagonists , 2010, Molecular Pharmacology.

[6]  E. Hamel,et al.  Antimitotic natural products combretastatin A-4 and combretastatin A-2: studies on the mechanism of their inhibition of the binding of colchicine to tubulin. , 1989, Biochemistry.

[7]  Ben Cornett,et al.  The Binding Mode of Epothilone A on α,ß-Tubulin by Electron Crystallography , 2004, Science.

[8]  Raimond B G Ravelli,et al.  Variations in the colchicine-binding domain provide insight into the structural switch of tubulin , 2009, Proceedings of the National Academy of Sciences.

[9]  R. Costi,et al.  Novel in vitro Highly Active Antifungal Agents with Pyrrole and Imidazole Moieties. , 1992 .

[10]  A. Tedeschi,et al.  RanBP1 downregulation sensitizes cancer cells to taxol in a caspase-3-dependent manner , 2009, Oncogene.

[11]  E. Stenhagen,et al.  Preparation of Cis- and Trans 2,5-Dimethoxy-2-(acetamidomethyl)-2,5-dihydrofuran, of Cis- and Trans 2,5-Dimethoxy-2-(acetamidomethyl)-tetrahydrofuran and of 1-Phenyl-2-(acetamidomethyl)-pyrrole. , 1952 .

[12]  J. N. Kumar,et al.  Novel Approach for the Synthesis of N-Substituted Pyrroles Starting Directly from Nitro Compounds in Water , 2012 .

[13]  Jianhui Wang,et al.  Synthesis of Pyrrole Derivatives from Diallylamines by One-Pot Tandem Ring-Closing Metathesis and Metal-Catalyzed Oxidative Dehydrogenation , 2013 .

[14]  W. Gerwick,et al.  Structure-activity analysis of the interaction of curacin A, the potent colchicine site antimitotic agent, with tubulin and effects of analogs on the growth of MCF-7 breast cancer cells. , 1998, Molecular pharmacology.

[15]  David S. Goodsell,et al.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..

[16]  B. Bhattacharyya,et al.  Anti‐mitotic activity of colchicine and the structural basis for its interaction with tubulin , 2008, Medicinal research reviews.

[17]  Y. Ni,et al.  Toward highly potent cancer agents by modulating the C-2 group of the arylthioindole class of tubulin polymerization inhibitors. , 2013, Journal of medicinal chemistry.

[18]  A. Mann,et al.  Acylthiourea, acylurea, and acylguanidine derivatives with potent hedgehog inhibiting activity. , 2012, Journal of medicinal chemistry.

[19]  B. Teicher.  Newer Cytotoxic Agents: Attacking Cancer Broadly , 2008, Clinical Cancer Research.

[20]  Thomas Stützle,et al.  Empirical Scoring Functions for Advanced Protein-Ligand Docking with PLANTS , 2009, J. Chem. Inf. Model..

[21]  M. Jordan,et al.  Microtubules as a target for anticancer drugs , 2004, Nature Reviews Cancer.

[22]  I. Barasoain,et al.  Cyclostreptin binds covalently to microtubule pores and lumenal taxoid binding sites. , 2007, Nature chemical biology.

[23]  Mathias Schmidt,et al.  Mitotic drug targets and the development of novel anti-mitotic anticancer drugs. , 2007, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[24]  K. R. Rao,et al.  New strategy for the synthesis of N-aryl pyrroles: Cu-catalyzed C–N cross-coupling reaction of trans-4-hydroxy-l-proline with aryl halides , 2011 .

[25]  T. Skrydstrup,et al.  Carbonylative Heck reactions using CO generated ex situ in a two-chamber system. , 2011, Organic letters.

[26]  Patrick A. Curmi,et al.  Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain , 2004, Nature.

[27]  Bryan L. Roth,et al.  Structure of the human smoothened receptor bound to an antitumour agent , 2013, Nature.

[28]  S. Peukert,et al.  Small‐Molecule Inhibitors of the Hedgehog Signaling Pathway as Cancer Therapeutics , 2010, ChemMedChem.

[29]  J. Naval,et al.  Antimitotic drugs in cancer chemotherapy: promises and pitfalls. , 2013, Biochemical pharmacology.

[30]  S. Peukert,et al.  Small‐Molecule Inhibitors of the Hedgehog Signaling Pathway as Cancer Therapeutics , 2010, ChemMedChem.

[31]  Andrea Brancale,et al.  The Tubulin Colchicine Domain: a Molecular Modeling Perspective , 2012, ChemMedChem.

[32]  M. Andreeff,et al.  Attenuation of WAF1/Cip1 expression by an antisense adenovirus expression vector sensitizes glioblastoma cells to apoptosis induced by chemotherapeutic agents 1,3-bis(2-chloroethyl)-1-nitrosourea and cisplatin. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[33]  C. Wermuth,et al.  Chapter 16 – Ring Transformations , 2008 .

[34]  E. Nogales,et al.  High-Resolution Model of the Microtubule , 1999, Cell.

[35]  Carlos Alfonso,et al.  Stathmin and Interfacial Microtubule Inhibitors Recognize a Naturally Curved Conformation of Tubulin Dimers* , 2010, The Journal of Biological Chemistry.

[36]  E. Hamel.  Evaluation of antimitotic agents by quantitative comparisons of their effects on the polymerization of purified tubulin , 2007, Cell Biochemistry and Biophysics.

[37]  Duane D. Miller,et al.  Discovery of novel 2-aryl-4-benzoyl-imidazoles targeting the colchicines binding site in tubulin as potential anticancer agents. , 2010, Journal of medicinal chemistry.

[38]  E. Novellino,et al.  New arylthioindoles and related bioisosteres at the sulfur bridging group. 4. Synthesis, tubulin polymerization, cell growth inhibition, and molecular modeling studies. , 2009, Journal of medicinal chemistry.